Trial intelligence / Profile preview

Etanercept for Discoid Lupus Erythematosus

NCT00797784Phase 2Unknown

Sponsor
Florida Academic Dermatology Centers
Start
Oct 2008
Primary completion
Apr 2011
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of etanercept in discoid lupus erythematosus (DLE), sponsored by Florida Academic Dermatology Centers. Status: unknown.

02

Drugs

etanercept
03

Conditions

discoid lupus erythematosus (DLE)

Beyond the preview

Go deeper on NCT00797784.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00797784.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call